ID Source | ID |
---|---|
PubMed CID | 128882 |
SCHEMBL ID | 905456 |
MeSH ID | M0141312 |
Synonym |
---|
adenosine 3'-(dihydrogen phosphate) 5'-(trihydrogen diphosphate) |
3'-phosphate-adenosine-5'-diphosphate |
DB01842 |
1AFK , |
adenosine 3'-phosphate 5'-diphosphate |
[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl phosphono hydrogen phosphate |
5'-diphosphoadenosine 3'-phosphate |
5'-ppap-3' |
3'-phosphoadenosine diphosphate |
3'-phospho-adp |
adenosine 5'-(trihydrogen diphosphate), 3'-(dihydrogen phosphate) |
13400-10-7 |
SCHEMBL905456 |
9-{5-o-[hydroxy(phosphonooxy)phosphoryl]-3-o-phosphonopentofuranosyl}-9h-purin-6-amine |
DTXSID90928385 |
PD060307 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, RIBONUCLEASE A | Bos taurus (cattle) | Ki | 0.2400 | 0.2400 | 0.2400 | 0.2400 | AID977610 |
Chain A, RIBONUCLEASE A | Bos taurus (cattle) | Ki | 0.2400 | 0.2400 | 0.2400 | 0.2400 | AID977610 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1811 | Experimentally measured binding affinity data derived from PDB | 1997 | Biochemistry, May-06, Volume: 36, Issue:18 | Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution. |
AID977610 | Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB | 1997 | Biochemistry, May-06, Volume: 36, Issue:18 | Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.05) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |